Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylintrosamine or phenobarbitone

Publisher Website
Google Scholar
Abstract
In a study of the mechanisms involved in the induction of tumours by chemicals, the Ha-ras oncogene was analysed in liver tumours induced by the genotoxic carcinogen diethylnitrosamine (DEN), or the non-genotoxic agent phenobarbitone (PB) in C3H/He mice. Mutations were detected using the polymerase chain reaction and oligonucleotide hybridization. Codon 61 mutations were detected in 41% of DEN-induced tumours (19/49), either in the fust base (CG → AT, 12/19), a transversion, or the second base (AT → GC, 7/19), a transition. Codon 61 mutations were also found in 29% of spontaneous tumours (all CG → AT, 6/21) but none were detected in PB-induced tumours (0/15) or in normal liver tissue of untreated mice (0/30). No mutations were detected at codon 12. Low and variable expression of the Ha-ras gene was detected in all liver tissues with moderately raised levels (175–200%) in spontaneous, DEN and PB-induced tumours as compared to normal liver tissue. The Ha-ras gene was methylated to some extent in all liver tissues, with no discernible difference between the treatments. The frequency of the Ha-ras mutation at codon 61 in DEN-induced tumours is greater than in spontaneously arising tumours. This increase is not accompanied by any specific alteration in the expression or methylation of the gene. Since PB-induced tumours do not possess mutations in the Ha-ras gene at codons 12 or 61, the data suggest that the nongenotoxic agent PB induces tumours in the C3H/He mouse liver with a mechanism distinct from that of spontaneous tumours or those that result from treatment with a potent genotoxic carcinogen such as DEN.

This publication has 0 references indexed in Scilit: